生長抑素及凝血酶在上消化道潰瘍出血治療中的應(yīng)用及安全性分析
發(fā)布時間:2018-08-29 14:22
【摘要】:目的:探討分析生長抑素、凝血酶聯(lián)合奧美拉唑治療上消化道潰瘍出血患者的臨床效果及安全性。方法:選取收治的64例急性上消化道出血患者采用隨機數(shù)字表法分為聯(lián)合組和對照組各32例,聯(lián)合組采用長抑素、凝血酶聯(lián)合奧美拉唑治療,對照組僅應(yīng)用奧美拉唑治療,兩組其余基礎(chǔ)治療相同,對比兩組患者的止血效果差異。結(jié)果:聯(lián)合組患者的止血時間(7.3±3.8)h、住院時間(10.4±2.2)d、出血量(441±108)m L均著低于對照組的(9.5±4.2)h、(12.7±3.4)d、(507±129)m L(P0.05);聯(lián)合組治療顯效率(81.25%)高于對照組(53.13%)(P0.05);治療后聯(lián)合組的血紅蛋白(Hb)(109.5±10.4)g/L、紅細胞(RBC)(4.5±0.8)×109/L、血小板(PLT)(147.2±19.3)×109/L、紅細胞壓積(Hct)(41.3±6.9)%,優(yōu)于對照組患者的(101.5±9.2)g/L、(3.7±0.7)×109/L、(131.5±17.8)×109/L、(36.4±7.0)%,(P0.05);治療后聯(lián)合組的凝血酶原時間(PT)(10.8±1.9)s、部分活化凝血酶原時間(APTT)(28.6±3.9)s、纖維蛋白原(Fib)(392.5±51.4)mg/d L優(yōu)于對照組的(12.0±2.0)s、(30.1±4.4)s、(319.8±49.8)mg/d L(P0.05);聯(lián)合組的不良反應(yīng)率(31.25%)高于對照組(15.63%),但差異無統(tǒng)計學(xué)意義(P0.05)。結(jié)論:生長抑素、凝血酶聯(lián)合奧美拉唑治療急性上消化道出血較單用奧美拉唑的效果更好,且不增加不良反應(yīng)率。
[Abstract]:Objective: to investigate the efficacy and safety of somatostatin, thrombin and omeprazole in the treatment of upper gastrointestinal ulcer hemorrhage. Methods: 64 patients with acute upper gastrointestinal hemorrhage were randomly divided into two groups: the combined group (n = 32) and the control group (n = 32). The combined group was treated with somatostatin, thrombin and omeprazole, while the control group was treated with omeprazole only. The other basic treatment was the same in the two groups, and the hemostatic effect was different between the two groups. Results: the hemostasis time, hospitalization time and bleeding volume of the combined group were (7.3 鹵3.8) h and (10.4 鹵2.2) d, respectively, which were significantly lower than those of the control group (9.5 鹵4.2) h, (, 12.7 鹵3.4) d, (, 507 鹵129) m L (, P0.05), the effective rate of treatment in the combined group (81.25%) was higher than that in the control group (53.13%) (P0.05), the hemoglobin (Hb) (109.5 鹵10.4 g / L, erythrocyte (RBC) (4.5 鹵0.8 脳 109 / L, platelet (PLT) (147.2 鹵19.3 脳 109 / L, erythrocyte (PLT) (147.2 鹵19.3 脳 109 / L, erythrocyte (RBC) (4.5 鹵0.8 脳 109 / L / L, erythrocyte (PLT) (147.2 鹵19.3 脳 109 / L, respectively. 緇嗚優(yōu)鍘嬬Н(Hct)(41.3鹵6.9)%,浼樹簬瀵圭収緇勬?zhèn)h呯殑(101.5鹵9.2)g/L,(3.7鹵0.7)脳109/L,(131.5鹵17.8)脳109/L,(36.4鹵7.0)%,(P0.05);娌葷枟鍚庤仈鍚堢粍鐨勫嚌琛,
本文編號:2211465
[Abstract]:Objective: to investigate the efficacy and safety of somatostatin, thrombin and omeprazole in the treatment of upper gastrointestinal ulcer hemorrhage. Methods: 64 patients with acute upper gastrointestinal hemorrhage were randomly divided into two groups: the combined group (n = 32) and the control group (n = 32). The combined group was treated with somatostatin, thrombin and omeprazole, while the control group was treated with omeprazole only. The other basic treatment was the same in the two groups, and the hemostatic effect was different between the two groups. Results: the hemostasis time, hospitalization time and bleeding volume of the combined group were (7.3 鹵3.8) h and (10.4 鹵2.2) d, respectively, which were significantly lower than those of the control group (9.5 鹵4.2) h, (, 12.7 鹵3.4) d, (, 507 鹵129) m L (, P0.05), the effective rate of treatment in the combined group (81.25%) was higher than that in the control group (53.13%) (P0.05), the hemoglobin (Hb) (109.5 鹵10.4 g / L, erythrocyte (RBC) (4.5 鹵0.8 脳 109 / L, platelet (PLT) (147.2 鹵19.3 脳 109 / L, erythrocyte (PLT) (147.2 鹵19.3 脳 109 / L, erythrocyte (RBC) (4.5 鹵0.8 脳 109 / L / L, erythrocyte (PLT) (147.2 鹵19.3 脳 109 / L, respectively. 緇嗚優(yōu)鍘嬬Н(Hct)(41.3鹵6.9)%,浼樹簬瀵圭収緇勬?zhèn)h呯殑(101.5鹵9.2)g/L,(3.7鹵0.7)脳109/L,(131.5鹵17.8)脳109/L,(36.4鹵7.0)%,(P0.05);娌葷枟鍚庤仈鍚堢粍鐨勫嚌琛,
本文編號:2211465
本文鏈接:http://sikaile.net/yixuelunwen/xiaohjib/2211465.html
最近更新
教材專著